127 related articles for article (PubMed ID: 35063582)
1. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
[TBL] [Abstract][Full Text] [Related]
2. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
3. Using New Vaginal Doses Evaluation System to Assess the Dose-Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer.
Wang J; Zhang KS; Liu Z; Wang T; Wang RH; Zhang FQ; Yu L; Wang YL; Wei LC; Shi M; Li S; Liu BG; Shi F; Su J; Yuan W; Zhang QY; Zhang J
Front Oncol; 2022; 12():840144. PubMed ID: 35515128
[TBL] [Abstract][Full Text] [Related]
4. Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.
Wang J; Zhang KS; Wang T; Liu Z; Wang RH; Zhang FQ; Yu L; Ran L; He JL; Wang YL; Wei LC; Shi M; Wang GQ; Wu CQ; Kang QJ; Yang J; Li S; Yang FY; Liu BG; Liu JY; Shi F; Su J; Yuan W; Drokow EK
BMC Cancer; 2019 Dec; 19(1):1219. PubMed ID: 31842811
[TBL] [Abstract][Full Text] [Related]
5. Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?
Limkin EJ; Dumas I; Rivin Del Campo E; Chargari C; Maroun P; Annède P; Petit C; Seisen T; Doyeux K; Tailleur A; Martinetti F; Lefkopoulos D; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(2):169-76. PubMed ID: 26778755
[TBL] [Abstract][Full Text] [Related]
6. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
[TBL] [Abstract][Full Text] [Related]
7. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
[TBL] [Abstract][Full Text] [Related]
8. Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
Dankulchai P; Harn-Utairasmee P; Prasartseree T; Nakkasae P; Trikhirhisthit K; Sittiwong W; Thephamongkhol K; Petsuksiri J; Apiwarodom N; Iampongpaiboon P; Chansilpa Y
Radiother Oncol; 2022 Sep; 174():77-86. PubMed ID: 35839936
[TBL] [Abstract][Full Text] [Related]
9. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
[TBL] [Abstract][Full Text] [Related]
11. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
[TBL] [Abstract][Full Text] [Related]
12. The association of vagina equivalent dose in 2Gy fraction (EQD
Ruanla J; Muangwong P; Kittidachanan K; Tippanya D; Thongsuk W; Kongsa A; Galalae RM; Tharavichitkul E
Brachytherapy; 2022; 21(5):658-667. PubMed ID: 35715305
[TBL] [Abstract][Full Text] [Related]
13. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
[TBL] [Abstract][Full Text] [Related]
14. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
[TBL] [Abstract][Full Text] [Related]
15. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
[TBL] [Abstract][Full Text] [Related]
16. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S; Jensen NBK; Pötter R; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Hoskin P; Segedin B; Rai B; Bruheim K; Wiebe E; Van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Lutgens LCHW; Tan LT; Villafranca E; Smet S; Jastaniyah N; Nout RA; Kirisits C; Chopra S; Kirchheiner K; Tanderup K; Embrace Collaborative Group
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):681-693. PubMed ID: 34678431
[TBL] [Abstract][Full Text] [Related]
17. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
18. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
19. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis.
Spampinato S; Fokdal LU; Pötter R; Haie-Meder C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Huang F; Cooper R; van der Steen-Banasik E; Van Limbergen E; Sundset M; Westerveld H; Nout RA; Jensen NBK; Kirisits C; Kirchheiner K; Tanderup K;
Radiother Oncol; 2021 May; 158():300-308. PubMed ID: 33065183
[TBL] [Abstract][Full Text] [Related]
20. Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Vittrup AS; Kirchheiner K; Pötter R; Fokdal LU; Jensen NBK; Spampinato S; Haie-Meder C; Schmid MP; Sturdza AE; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Wiebe E; van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Kirisits C; Lindegaard JC; Jürgenliemk-Schulz IM; Nout R; Tanderup K;
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):807-824. PubMed ID: 36641039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]